Table 2. Magnitude of Difference Between the Burden of Disease Among the Recently Incarcerated vs Proportion of Total National Sales Perspective (NSP) Extended Units Distributed to the Incarcerated Population^a.

	Disease among recently incarcerated population, % (95% CI)	Total NSP to incarcerated population, %	Magnitude of difference (95% CI)b
Diabetes	0.44 (0.34-0.56)	0.15	2.86 (2.22-3.65)
Asthma	0.85 (0.67-1.06)	0.15	5.45 (4.32-6.83)
Hypertension	0.42 (0.35-0.51)	0.18	2.40 (1.98-2.89)
Hepatitis B or C	3.13 (2.53-3.84)	1.68	1.87 (1.51-2.29)
HIV	2.20 (1.51-3.19)	0.73	3.01 (2.06-4.37)
Depression	1.46 (1.33-1.59)	0.36	4.08 (3.73-4.45)
Severe mental illness	1.97 (1.81-2.14)	0.48	4.11 (3.78-4.46)

Abbreviation: HIV, human immunodeficiency virus.

^a Sources: 2018-2020 National Survey on Drug Use and Health,²¹ the US Census Bureau,²⁴ IQVIA’s National Sales Perspective.¹⁹ For asthma, Uniform System of Classification codes associated with asthma treatment under 28000 (respiratory treatment) were used. Hypertension: 41200 (diuretics), 31410 (β-blockers), 31110 (angiotensin-converting enzyme inhibitors), 31120 (angiotensin II antagonists), 31300 (calcium blockers), 31440 (α blockers), 31420 (α-β blockers), and 31450 (central-acting agents). Hepatitis: 82212 (hepatitis C antivirals), 86210 (immunologic interferons), and 82211 (hepatitis B antivirals). HIV: 82100 (HIV antivirals). Depression: 64310 (tricyclics and tetracyclics), 64320 (monoamine oxidase inhibitors), 64340 (selective serotonin reuptake inhibitors), 64350 (serotonin and noradrenaline reuptake inhibitors), and 64330 (other antidepressants). Severe mental illness: 64100 (antipsychotics) and 64400 (mood stabilizers).

^b The magnitude of difference represents a relative ratio. Dividing the first 2 columns will not equal the third column exactly due to rounding errors.